CWEB vs. MDP, LABS, WLLW, HLS, MBX, BCT, HBP, AEZS, and APS
Should you be buying Charlotte's Web stock or one of its competitors? The main competitors of Charlotte's Web include Medexus Pharmaceuticals (MDP), MediPharm Labs (LABS), Willow Biosciences (WLLW), HLS Therapeutics (HLS), Microbix Biosystems (MBX), BriaCell Therapeutics (BCT), Helix BioPharma (HBP), Aeterna Zentaris (AEZS), and Aptose Biosciences (APS). These companies are all part of the "medical" sector.
Charlotte's Web (TSE:CWEB) and Medexus Pharmaceuticals (TSE:MDP) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership and profitability.
Medexus Pharmaceuticals received 1 more outperform votes than Charlotte's Web when rated by MarketBeat users. Likewise, 100.00% of users gave Medexus Pharmaceuticals an outperform vote while only 0.00% of users gave Charlotte's Web an outperform vote.
5.2% of Charlotte's Web shares are owned by institutional investors. Comparatively, 11.4% of Medexus Pharmaceuticals shares are owned by institutional investors. 11.2% of Charlotte's Web shares are owned by insiders. Comparatively, 8.7% of Medexus Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Charlotte's Web has a beta of 2.23, meaning that its stock price is 123% more volatile than the S&P 500. Comparatively, Medexus Pharmaceuticals has a beta of 1.85, meaning that its stock price is 85% more volatile than the S&P 500.
Medexus Pharmaceuticals has a net margin of 5.08% compared to Charlotte's Web's net margin of -37.68%. Medexus Pharmaceuticals' return on equity of 26.14% beat Charlotte's Web's return on equity.
Medexus Pharmaceuticals has higher revenue and earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than Medexus Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
In the previous week, Charlotte's Web had 2 more articles in the media than Medexus Pharmaceuticals. MarketBeat recorded 3 mentions for Charlotte's Web and 1 mentions for Medexus Pharmaceuticals. Medexus Pharmaceuticals' average media sentiment score of 0.00 beat Charlotte's Web's score of -0.19 indicating that Medexus Pharmaceuticals is being referred to more favorably in the news media.
Summary
Medexus Pharmaceuticals beats Charlotte's Web on 12 of the 16 factors compared between the two stocks.
Get Charlotte's Web News Delivered to You Automatically
Sign up to receive the latest news and ratings for CWEB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CWEB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Charlotte's Web Competitors List
Related Companies and Tools
